Regulatory Approvals

FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis

By

Regulatory Approvals — FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis  NeurologyLive

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 16, 2026.

By

Related Post

Regulatory Approvals

FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease

Regulatory Approvals

FDA Approves New Nonprescription Treatment for Eye Redness

Regulatory Approvals

FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia

Financial News For All

Labor

Labor board won’t block California state worker strike, pending essential worker plan

Labor

California’s move to block SEIU Local 1000 state worker strike likely to fail

Labor

Union election at MedStar Franklin Square too close to call and marred by MedStar Health union busting

Labor

Graduate Student Union Schedules Strike